John Papadopoulos
@JPCritCarePharm
Followers
325
Following
482
Media
6
Statuses
310
Director of Clinical Pharmacy Services, Critical Care Pharmacist @NYULangone Tweets are my own.
New York, NY
Joined April 2020
✅ out our 📑 and a commentary of our 📑 on #digoxin for rate control of atrial arrhythmias in the #CICU & #CTICU 🫀 https://t.co/NIFqQiPYUB
@ColombianpharmD @CardsNYC @jameshorowitzmd @SamuelB316 @JPCritCarePharm @JCVPOnline @nyulangone @nyugrossman
journals.lww.com
or pharmacokinetic-based calculation to target a serum digoxin concentration (SDC) of 0.8–1.5 ng/mL is recommended. The objective of this study was to assess the safety and effectiveness of digoxin...
Optimizing Digoxin Use in Critically Ill Patients: Lessons from a Retrospective Study https://t.co/TbErpJGNsC
@MarcoDelBuono3 @simonefilomia
#Digoxin #AtrialFibrillation #CriticalCare #Pharmacology #Cardiology
0
6
7
0
2
12
🆕 📑 🚨 do you use valproic acid in your ICUs to manage hyperactive delirium or agitation? ✅ out our experience ⬇️ https://t.co/kfP4QxAmek
@olivia_nuti @ColombianpharmD @ArnoukSerena @JPCritCarePharm @AlyKatz2 @NYUPharmRes @nyulangone @NYULangoneBK @nyugrossman
journals.sagepub.com
Background Delirium and agitation are common syndromes in critically ill patients. Valproic acid (VPA) has shown benefit in intensive care unit (ICU)-associated...
0
3
11
who is at #ESCCongress2024 🫀🇬🇧? come by tomorrow 8/30 to hear about our experience w/ digoxin loading doses in critically ill! abstract➡️ https://t.co/hzvgLiwYdx…
@ColombianpharmD @JPCritCarePharm @jameshorowitzmd @CardsNYC @RaymondPashunMD @SamuelB316 @nyugrossman @nyulangone
0
3
9
got to present on behalf of our #CICU & #pharmacy @ #ESCCongress2024 in 🇬🇧 ✅ 🫶🏼 to @nyugrossman 🫀 faculty & fellows who came to support! @rebeccacastromd @JDodsonMD
who is at #ESCCongress2024 🫀🇬🇧? come by tomorrow 8/30 to hear about our experience w/ digoxin loading doses in critically ill! abstract➡️ https://t.co/hzvgLiwYdx…
@ColombianpharmD @JPCritCarePharm @jameshorowitzmd @CardsNYC @RaymondPashunMD @SamuelB316 @nyugrossman @nyulangone
2
2
16
#1 in New York and now tied for #1 in the United States in Pulmonology and Lung Surgery! This is a testament to our multidisciplinary team of pulmonologists, thoracic surgeons, NPs, RTs, and PharmDs all dedicated to patients with lung disorders. @nyugrossman
9
17
93
Also a big congratulations to our wonderful PGY1 class of 2023-2024 on completing their residency year!
0
2
9
Congratulations to our PGY2 residents on graduating last week! We are so proud of your achievements and wish you all the best on your future endeavors!
0
2
9
Excited to share @nyulangone's real-world #maribavir utilization in SOTRs and HSCTRs @ #ESCMIDGlobal2024! @SapnaMehtaMD @awongpharmd @RoshaniPatolia @JulieDPharmD @NYUGSOM_ID
1
3
14
A multidisciplinary team @nyulangone discusses Catheter-based therapy for high-risk or intermediate-risk #pulmonaryembolism: death and re-hospitalization in @escardio @ehj_ed 🔓 https://t.co/kAtcUHAcEW
#PERT #Meded #PCCM #Cardiology #CriticalCare
0
2
6
✅ out our 🆕 article in press! 🫀🎈 🎈heparin is associated with 🩸& thrombocytopenia, though true HIT incidence in our cohort was 0️⃣ 🎈do we need less intense anticoagulant targets or strategies w/IABP? 🎈VTE incidence may be unrelated read here!⤵️ https://t.co/qD8ME39KNp
0
12
29
Introducing our 2024-2025 PGY-2 pharmacy residency class!
0
4
17
We are so excited to welcome our incoming class of 2024-2025 PGY-1 pharmacy residents!
0
5
16
Optimizing cangrelor use in critically ill patients: insights from a retrospective cohort study #medicine
https://t.co/ZsQb2m36Yd
@AjconneryPharmD @TaniaAhuja @AlyKatz2 @ArnoukSerena @zhu_syn @JPCritCarePharm @SVRaoMD @ColombianpharmD @nyulangone @nyugrossman @nyuPharmRes
0
9
17
All acetaminophen tablet and liquid products manufactured should have N-acetylcysteine as a vital co-ingredient. This strategy can be a preemptive approach in the management of intentional or accidental APAP poisonings.
0
0
4
✅ out our P2Y12 PRU-guided approach to cangrelor use in critically ill🫀👥 w/45% of our cohort on MCS, ahead of print! @AjconneryPharmD @AlyKatz2 @ArnoukSerena @zhu_syn @JPCritCarePharm @SVRaoMD @ColombianpharmD @nyulangone @nyugrossman @JCVPOnline
https://t.co/juR6SRvpTY
0
7
30
Drs. Eugene Yuriditsky (@CardsNYC) and James Horowitz (@jameshorowitzmd), who have contributed seminal articles on managing severe PE, summarize best practices for acute intensive care medical management.
evtoday.com
An exploration of pharmacologic and mechanical circulatory support, respiratory management, and emergent reperfusion for managing acute PE.
1
18
46
I would vote false. 10 grams may be excessive in low body weight patients and a potential under-dose in high body weight patients.
True or False: Amiodarone total loading dose should be 10 grams (enteral equivalent) irrespective of a patient’s body weight, body habitus or type of dysrhythmia being treated.
0
0
5
NAC IV in APAP OD clinical pearl: I use concomitant 3% saline (20ml/hr) via a peripheral line to prevent or correct hyponatremia, with a goal sodium between 140-142 (my opinion). Sodium goal may change with altered mental status, hyperammonemia, or evidence of cerebral edema.
0
0
2
True or False: Amiodarone total loading dose should be 10 grams (enteral equivalent) irrespective of a patient’s body weight, body habitus or type of dysrhythmia being treated.
0
0
3